MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease

P. Zeun, P. McColgan, T. Dhollander, S. Gregory, E. Johnson, M. Papoutsi, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

Meeting: MDS Virtual Congress 2020

Abstract Number: 268

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis, Magnetic resonance imaging(MRI)

Category: Huntington's Disease

Objective: To identify when white matter connections first begin to degenerate in HD and which connections are most susceptible to early degeneration.

Background: Huntington’s disease (HD) is a progressive neurodegenerative condition characterised by selective vulnerability of the basal ganglia and associated white matter connections many years before symptom onset. Emerging therapies, such as RNAi and CRISPR will require injecting specific basal-ganglia sub-regions, however which sub-regions have the most vulnerable white matter connections and when they first begin to degenerate is unknown.

Method: We included 277 individuals, from 2 separate studies, HD-YAS with HD gene carriers 24 years from disease onset imaged at one time point and TrackOn-HD with HD gene expansion carriers 10 years from disease onset imaged at three time points over 2 years. We used diffusion MRI tractography and fixel based analysis, which resolves crossing fibres at the voxel level, to investigate basal ganglia sub-region white matter loss. Differences in a measure of fibre density and cross section were compared between gene carriers and matched controls for 7 cortico-striatal and 7 cortico-thalamic tracts.

Results: We found no significant differences in basal ganglia white matter loss in gene carriers 24 years from onset suggesting basal ganglia white matter is normal at this time. However in a cohort 10 years from onset, there were widespread changes in cortico-striatal and cortico-thalamic connectivity at baseline with limbic and motor white matter connections showing greatest vulnerability to presymptomatic neurodegeneration.

Conclusion: For the first time our findings provide time and anatomical specificity of basal ganglia white matter loss in HD. This has important implications for the initiation and anatomical targeting of future disease modifying therapies, where treatment at 24 years from predicted clinical onset could potentially prevent degeneration of white matter connections in HD.

To cite this abstract in AMA style:

P. Zeun, P. McColgan, T. Dhollander, S. Gregory, E. Johnson, M. Papoutsi, R. Scahill, G. Rees, S. Tabrizi. Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/defining-time-and-anatomical-specificity-of-basal-ganglia-white-matter-loss-in-premanifest-huntingtons-disease/. Accessed December 10, 2023.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/defining-time-and-anatomical-specificity-of-basal-ganglia-white-matter-loss-in-premanifest-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Carpal Tunnel Syndrome in Patients with Tremor
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley